Literature DB >> 24715737

Scopolamine patch withdrawal syndrome.

Steve H Lau1, Chris Vaneaton2.   

Abstract

Entities:  

Year:  2014        PMID： 24715737      PMCID： PMC3971103          DOI： 10.1310/hpj4903-218

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN： 0018-5787


× No keyword cloud information.
  4 in total

1.  Central nervous system supersensitivity to pilocarpine after withdrawal of chronically administered scopolamine.

Authors:  M J Friedman; J H Jaffe; S K Sharpless
Journal:  J Pharmacol Exp Ther       Date:  1969-05       Impact factor: 4.030

2.  Scopolamine withdrawal syndrome.

Authors:  K Saxena; S Saxena
Journal:  Postgrad Med       Date:  1990-01       Impact factor: 3.840

3.  Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: treatment with meclizine.

Authors:  Priti N Patel; Danielle C Ezzo
Journal:  Am J Health Syst Pharm       Date:  2009-11-15       Impact factor: 2.637

Review 4.  Motion sickness.

Authors:  John F Golding; Michael A Gresty
Journal:  Curr Opin Neurol       Date:  2005-02       Impact factor: 5.710
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.